Articles & Video
BioProcess International Fall Digital Week 2020
We explore the agenda for the upcoming BioProcess International Fall Digital Week 2020.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
63% of cell and gene therapy professionals changed their supply chain strategies due to COVID-19
We examine new data on the challenges in cell and gene therapy supply chain and manufacturing as a result of the COVID-19 pandemic.
Human Monoclonal Antibodies for SARS-CoV-2
We look at single cell technologies for the isolation of human monoclonals, the molecular basis for SARS-CoV-2 neutralization and antibody synergistic exploration.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
REPORT: COVID-19 Response in Cell & Gene Therapy Manufacturing 2021
This exclusive report uncovers the major changes in the cell and gene therapy sector during the COVID-19 pandemic.
Scaling up manufacturing when it’s needed most
Learn how Thermo Fisher Scientific scaled up raw material manufacturing for mRNA production, leaning on decades of experience.
Survey: Cell & Gene Therapy COVID-19 Response
What changes are happening in the cell and gene therapy sector as a result of the pandemic? Tell us your experience.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Pharma’s role in maintaining cancer mortality progress during COVID-19
COVID-19 is threatening the progress made in reducing cancer mortality. Pharma has a pivotal role to play in helping patients and providers navigate the new reality of cancer treatment during the pandemic, and beyond.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Women in Pharma: 44% of pharma professionals think that women are under represented in their organization
44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
42% of pharma industry believe cell and gene therapies to be most promising therapeutics
According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
The biggest breakthroughs in life sciences the last 10 years
CRISPR, CAR-T, immunotherapies, genome sequencing, AI - what is the biggest breakthrough in the life sciences in the last 10 years?
Future Trends in Proteins To Fight COVID-19
The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.